Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul;15(3):127-152.
doi: 10.1007/s10388-018-0614-z. Epub 2018 Apr 18.

Comprehensive Registry of Esophageal Cancer in Japan, 2011

Yuji Tachimori  1 , Soji Ozawa  2 , Hodaka Numasaki  3 , Ryu Ishihara  4 , Hisahiro Matsubara  5 , Kei Muro  6 , Tsuneo Oyama  7 , Yasushi Toh  8 , Harushi Udagawa  9 , Takashi Uno  10 ; Registration Committee for Esophageal Cancer of the Japan Esophageal Society
Affiliations

Comprehensive Registry of Esophageal Cancer in Japan, 2011

Yuji Tachimori et al. Esophagus. 2018 Jul.

Erratum in

  • Correction to: Comprehensive Registry of Esophageal Cancer in Japan, 2011.
    Tachimori Y, Ozawa S, Numasaki H, Ishihara R, Matsubara H, Muro K, Oyama T, Toh Y, Udagawa H, Uno T; Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Tachimori Y, et al. Esophagus. 2018 Oct;15(4):304-305. doi: 10.1007/s10388-018-0624-x. Esophagus. 2018. PMID: 29948478 Free PMC article.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Ethical Statement

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

Informed consent

Informed consent or substitute for it was obtained from all patients for being included in the study.

Conflict of interest

All authors have nothing to disclose with regard to commercial support.

Figures

Fig. 1
Fig. 1
Survival of patients treated with EMR/ESD
Fig. 2
Fig. 2
Survival of patients treated with EMR/ESD according to the pathological depth of tumor invasion (pT)
Fig. 3
Fig. 3
Survival of patients treated with EMR/ESD according to the lymphatic and venous invasion
Fig. 4
Fig. 4
Survival of patients treated with chemotherapy and/or radiotherapy
Fig. 5
Fig. 5
Survival of patients treated with definitive chemoradiotherapy according to clinical stage (UICC TNM 7th)
Fig. 6
Fig. 6
Survival of patients underwent radiotherapy alone according to clinical stage (UICC TNM 7th)
Fig. 7
Fig. 7
Survival of patients who underwent esophagectomy
Fig. 8
Fig. 8
Survival of patients who underwent esophagectomy according to clinical stage (JES 10th)
Fig. 9
Fig. 9
Survival of patients who underwent esophagectomy according to clinical stage (UICC 7th)
Fig. 10
Fig. 10
Survival of patients who underwent esophagectomy according to the depth of tumor invasion, pT (JES 10th)
Fig. 11
Fig. 11
Survival of patients who underwent esophagectomy according to lymph node metastasis, pN (JES 10th)
Fig. 12
Fig. 12
Survival of patients who underwent esophagectomy according to lymph node metastasis, pN (UICC 7th)
Fig. 13
Fig. 13
Survival of patients who underwent esophagectomy according to pathological stage (JES 10th)
Fig. 14
Fig. 14
Survival of patients who underwent esophagectomy according to pathological stage (UICC TNM 7th)
Fig. 15
Fig. 15
Survival of patients who underwent esophagectomy according to residual tumor (R)
See this image and copyright information in PMC

MeSH terms

LinkOut - more resources